A single centre retrospective study of low dose prophylaxis with extended half-life factor IX for severe haemophilia B.

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)

This study shows that EHL-FIX given at low doses can be effective for prevention of bleeding for persons with severe haemophilia B.

Keyphrases